Telemonitoring modalities in heart failure: comparative effectiveness across the heart failure population—a meta-analysis - Report - MDSpire

Telemonitoring modalities in heart failure: comparative effectiveness across the heart failure population—a meta-analysis

  • By

  • Niels T. B. Scholte

  • Pascal R. D. Clephas

  • Eric Boersma

  • Muhammed T. Gürgöze

  • Eelko Ronner

  • Lida Feyz

  • Rudolf A. de Boer

  • Robert M. A. van der Boon

  • Jasper J. Brugts

  • February 10, 2026

  • 0 min

Share

Comparative Effectiveness of Telemonitoring Approaches in Heart Failure

Overview

A meta-analysis of 79 randomized trials involving 31,669 heart failure patients demonstrated that remote monitoring (RM) significantly reduces total and first heart failure hospitalisations as well as all-cause mortality. Different RM modalities showed varying effectiveness, with invasive hemodynamic monitoring ranking highest for reducing total hospitalisations and structured telephone support most effective for first hospitalisation and mortality reduction.

Background

Heart failure (HF) is a chronic condition with high morbidity and mortality, necessitating effective management strategies to reduce hospitalisations and improve survival. Remote monitoring (RM) technologies have emerged as promising tools to manage HF patients by enabling early detection of decompensation and timely intervention. However, it remains unclear which RM modalities are most beneficial and which patient subgroups derive the greatest advantage. This meta-analysis aimed to compare the effectiveness of various RM approaches across diverse patient populations and clinical settings.

Data Highlights

OutcomeEffect MeasureValue (95% CI)
Total HF HospitalisationsIncidence Rate Ratio0.81 (0.72–0.91)
First HF HospitalisationRisk Ratio0.82 (0.76–0.88)
All-Cause MortalityRisk Ratio0.90 (0.84–0.95)

Key Findings

  • Remote monitoring reduces total heart failure hospitalisations by 19% compared to standard care.
  • First heart failure hospitalisations are reduced by 18% with remote monitoring interventions.
  • All-cause mortality is decreased by 10% among patients receiving remote monitoring.
  • Invasive hemodynamic monitoring ranks highest for reducing total HF hospitalisations based on network meta-analysis.
  • Structured telephone support ranks highest for reducing first HF hospitalisation and all-cause mortality.
  • Benefits of remote monitoring are consistent across geographic regions, HF status, age, sex, ejection fraction, and NYHA class without significant interaction effects.

Clinical Implications

Remote monitoring should be broadly implemented in heart failure management as it consistently improves hospitalisation and mortality outcomes across diverse patient groups. Clinicians may consider invasive hemodynamic monitoring for patients at high risk of recurrent hospitalisations and structured telephone support to reduce initial hospitalisation and mortality. Current evidence does not support tailoring RM modalities to specific patient characteristics, emphasizing the value of widespread RM adoption.

Conclusion

Remote monitoring significantly improves clinical outcomes in heart failure patients regardless of demographic or clinical characteristics. While different RM modalities vary in effectiveness, broad use of RM is supported to reduce hospitalisations and mortality in this population.

References

  1. Scholte et al. 2023 -- Telemonitoring for heart failure: a meta-analysis
  2. Inglis et al. 2015 -- Structured telephone support or non-invasive telemonitoring for patients with heart failure
  3. Clephas et al. 2023 -- Efficacy of pulmonary artery pressure monitoring in patients with chronic heart failure
  4. Curtain et al. 2022 -- Efficacy of implantable haemodynamic monitoring in heart failure
  5. Anker et al. 2011 -- Telemedicine and remote management of patients with heart failure

Original Source(s)

Related Content